CLINICAL TRIALS PROFILE FOR SEROQUEL XR
✉ Email this page to a colleague
All Clinical Trials for Seroquel XR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00034905 ↗ | A Comparison of Seroquel vs. Risperidone in Schizophrenia | Completed | AstraZeneca | Phase 4 | 2001-07-01 | The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks. |
NCT00043849 ↗ | Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) | Completed | National Institute on Aging (NIA) | Phase 4 | 2002-07-01 | The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia [PDD] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism. |
NCT00044655 ↗ | Switching Medication to Treat Schizophrenia | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2001-07-01 | This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Seroquel XR
Condition Name
Clinical Trial Locations for Seroquel XR
Trials by Country
Clinical Trial Progress for Seroquel XR
Clinical Trial Phase
Clinical Trial Sponsors for Seroquel XR
Sponsor Name